Reset filter
Keywords
Non Small Cell Lung Cancer ×
Mostra di più Keywords
Sommario
  1. 1. Test clinico
  2. 2. Documentazione di routine
  3. 3. Registro / studio di coorte
  4. 4. Garanzia di qualità
  5. 5. Dati Standard
  6. 6. Risultato segnalato dal paziente
  7. 7. Specialità mediche
    1. 7.1. Anestesiologia
    1. 7.2. Dermatologia
    1. 7.3. orecchio naso gola
    1. 7.4. Geriatria
    1. 7.5. Ginecologia / Ostetricia
    1. 7.6. Medicina Interna
      1. Ematologia
      1. Malattie infettive
      1. Cardiologia / Angiologia
      1. pneumologia
      1. Gastroenterologia
      1. Nefrologia
      1. Endocrinologia / Malattie metaboliche
      1. Reumatologia
    1. 7.7. Neurologia
    1. 7.8. Oftalmologia
    1. 7.9. Cure palliative
    1. 7.10. Patologia / Forense
    1. 7.11. Pediatria
    1. 7.12. Psichiatria / Psicosomatica
    1. 7.13. Radiologia
    1. 7.14. Chirurgia
      1. Chirurgia generale / viscerale
      1. Neurochirurgia
      1. Chirurgia plastica
      1. Chirurgia toracica
      1. Trauma / Ortopedia
      1. Chirurgia vascolare
    1. 7.15. Urologia
    1. 7.16. Medicina odontoiatrica / OMS
Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

19 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Eligibility Solid Tumors, NSCLC, Biliary and Bladder Cancer NCT02240238

- 01/10/20 - 1 modulo, 2 itemgroups, 9 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02240238

Eligibility Carcinoma, Non-Small-Cell Lung NCT01261299

- 28/10/19 - 1 modulo, 2 itemgroups, 13 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01261299

Eligibility Stage III Non-small Cell Lung Cancer NCT02076282

- 10/07/19 - 1 modulo, 2 itemgroups, 15 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
MRI Optimization Study in Stage III NSCLC; ODM derived from: https://clinicaltrials.gov/show/NCT02076282

Eligibility Recurrent Non-small Cell Lung Cancer NCT02059889

- 27/06/19 - 1 modulo, 2 itemgroups, 10 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02059889

Eligibility Non-Small Cell Lung Cancer NCT00667082

- 21/07/18 - 1 modulo, 2 itemgroups, 14 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Proteasome Inhibitor NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00667082

Eligibility Non Small Cell Lung Cancer NCT00415363

- 18/05/17 - 1 modulo, 2 itemgroups, 10 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00415363

Eligibility Lung Cancer, Non-Small Cell NCT00390806

- 23/04/17 - 1 modulo, 2 itemgroups, 21 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00390806

Eligibility Lung Cancer NCT00403065

- 23/04/17 - 1 modulo, 1 ItemGroup, 13 elementi, 1 linguaggio
ItemGroup: Criteria
Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT00403065

Eligibility Non-small Cell Lung Cancer NCT01130766

- 27/07/18 - 1 modulo, 2 itemgroups, 9 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT01130766

Eligibility Non-Small Cell Lung Cancer NCT00800202

- 09/01/19 - 1 modulo, 2 itemgroups, 9 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis; ODM derived from: https://clinicaltrials.gov/show/NCT00800202

Eligibility Non-small Cell Lung Cancer NCT00327288

- 20/05/17 - 1 modulo, 2 itemgroups, 13 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00327288

Eligibility Carcinoma NCT00243347

- 25/01/17 - 1 modulo, 2 itemgroups, 13 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00243347

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial